Healthcare -
Drug Manufacturers - General - NYSE - DK
$ 90.65
1.6 %
$ 399 B
Market Cap
28.51
P/E
NVO - REVENUE
Revenue NVO - Novo Nordisk A/S
290 B
LAST VALUE
28.11%
2 YEAR CAGR
18.94%
5 YEAR CAGR
12.58%
10 YEAR CAGR